Stockreport

Elevation Oncology Expands Ongoing Phase 1 Clinical Trial of EO-3021 Globally, Dosing First Patient in Japan [Yahoo! Finance]

Elevation Oncology, Inc. - Common stock  (ELEV) 
PDF BOSTON Feb. 22, 2024 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cance [Read more]